Tscan Therapeutics Inc (TCRX)
1.4100 -0.0400 (-2.76%) 13:14 ET [NASDAQ]
1.4100 x 5 1.4400 x 434
Realtime by (Cboe BZX)
1.4100 x 5 1.4400 x 434
Realtime 1.4300 -0.0200 (-1.38%) 08:48 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,499 | -91,690 | -61,803 | -30,142 | -89,218 |
| Depreciation Amortization | 4,108 | 3,397 | 2,370 | 1,254 | 5,361 |
| Accounts payable and accrued liabilities | 1,994 | 1,011 | -14 | -410 | -52 |
| Other Working Capital | 5,054 | -205 | 74 | -2,109 | 17,606 |
| Other Operating Activity | 5,521 | 4,077 | 3,881 | 2,140 | 4,945 |
| Operating Cash Flow | $-110,822 | $-83,410 | $-55,492 | $-29,267 | $-61,358 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,825 | -2,937 | -1,567 | -705 | -3,146 |
| Purchase Of Investment | -241,445 | -194,116 | -57,133 | -8,779 | -77,613 |
| Sale Of Investment | 192,657 | 117,147 | 61,147 | 45,647 | 20,000 |
| Investing Cash Flow | $-52,613 | $-79,906 | $2,447 | $36,163 | $-60,759 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 32,457 | N/A | N/A | N/A | N/A |
| Debt Repayment | -17,144 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 193,452 | 163,075 | 161,845 | 258 | 135,443 |
| Financing Cash Flow | $208,765 | $163,075 | $161,845 | $258 | $135,443 |
| Beginning Cash Position | 138,390 | 138,390 | 138,390 | 138,390 | 125,064 |
| End Cash Position | 183,720 | 138,149 | 247,190 | 145,544 | 138,390 |
| Net Cash Flow | $45,330 | $-241 | $108,800 | $7,154 | $13,326 |
| Free Cash Flow | |||||
| Operating Cash Flow | -110,822 | -83,410 | -55,492 | -29,267 | -61,358 |
| Capital Expenditure | -3,825 | -2,937 | -1,567 | -705 | -3,146 |
| Free Cash Flow | -114,647 | -86,347 | -57,059 | -29,972 | -64,504 |